Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Change in Receivables (2016 - 2017)

Anaptysbio's Change in Receivables history spans 2 years, with the latest figure at -$1.2 million for Q1 2017.

  • For Q1 2017, Change in Receivables fell 3400.0% year-over-year to -$1.2 million; the TTM value through Dec 2017 reached -$1.2 million, down 122400.0%, while the annual FY2017 figure was -$1.2 million, 122400.0% down from the prior year.
  • Change in Receivables reached -$1.2 million in Q1 2017 per ANAB's latest filing, down from $365000.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $365000.0 in Q4 2016 to a low of -$1.2 million in Q1 2017.